Demo
Close Language Tab
Locate us
Languages
I
Indoco Remedies Ltd Pharmaceuticals
₹ 280.55 +5.30 (1.93%)
  • NSE
  • BSE

Overview

  • BSE Code 532612
  • NSE Symbol INDOCO
  • ISIN Demat INE873D01024
  • Book Value (₹) 119.61
  • Face Value (₹) 2.00
  • Market Cap (₹ Cr.) 2,604.62
  • P/E (TTM) 0.00
  • EPS (TTM) 0.00
  • Div Yield (%) 0.07

Performance

Today’s Low 274.00
Today’s High 282.60

280.55
52W Low 190.00
52W High 355.00

280.55
Open 277.90
Prev. Close 275.25
Volume 36,097.00

Corporate Actions

Indoco Remedies Limited - Trading Window
Sep 30, 2025

Indoco Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Indoco Remedies Limited - Certificate under SEBI (Depositories and Participants) Regulations, 2018
Apr 07, 2025

Indoco Remedies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

About Indoco Remedies Ltd

Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations, with some presence in contract manufacturing and research. It also trades some active pharma ingredients (APIs) manufactured by a group company. _x000D_ _x000D_ Currently, Indoco has a presence in the therapeutic segments including anti-infective, anti-cold preparation, opthalmic, anti-spasmodic, stomatology, anti-inflammatory and anti-fungal. As per AC Nielsen ORG-MARG market survey (August 2004) of doctors, Indoco ranked first in the stomatology, ninth in the opthalmic and twelve in the pediatric segments in terms of prescription generation in the domestic market. In the overall pharma industry, Indoco is ranked 34th as per AC Nielsen ORG-MARG Retail Audit, but ranked 23rd in terms of prescription generation, indicating the strength of its marketing network. Further, the company last year launched a new super specialty division, with focus on diabetic and cardio-vascular segments. Its entry into the lifestyle segment with a strong presence in the prescription segment would augur well for the higher- than-average industry growth. _x000D_ _x000D_ Currently, Indoco has four manufacturing facilities. Two are located in Mumbai and two in Goa, and an R&D centre in Mumbai. The solid dosage facility in Goa has been accredited by UK-Medicines and Healthcare Products Regulatory Agency (MHRA), and the sterile plant of Goa has been designed as per US Food and Drug Administration (FDA) norms. On the selling front, it has a marketing network of 1,248 medical representatives._x000D_
Founded: 1947
Chairman: Suresh G Kare
Managing Director: Aditi Kare Panandikar
Address: Indoco House 166 C S T Road, Santacruz (East) Kalina, Mumbai, Maharashtra, 400098,

Frequently Asked Questions

What is the price of Indoco Remedies Ltd share today? +
How to buy stock of Indoco Remedies Ltd? +
What is the 52 Week High and Low of Indoco Remedies Ltd? +
What is the Market Cap of Indoco Remedies Ltd? +